GlassScriptPhysician profile
Yun S Sun
NPI 1316913098
$9,111.28
in general payments reported to CMS, 2019-2025
57 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,108 · 2020: $922 · 2021: $1,122 · 2022: $972 · 2023: $1,289 · 2024: $1,308 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,986.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,384.74 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Collegium Pharmaceutical, INC. | $795.29 | 2019-2025 | Belbuca, Xtampza |
| Amgen INC. | $781.76 | 2019-2024 | Repatha, Otezla |
| Abbvie INC. | $679.76 | 2021-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $632.49 | 2019-2025 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $573.46 | 2019-2025 | Airsupra, Farxiga |
| Forte Bio-Pharma LLC | $339.13 | 2019-2024 | Prolate, Nalocet |
| Exact Sciences Corporation | $323.23 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $321.93 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $301.26 | 2019-2024 | Xifaxan, Relistor, Trulance |
| Allergan, INC. | $299.31 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $184.24 | 2025 | Caplyta |
| Virtus Pharmaceuticals LLC | $181.40 | 2021-2025 | Levorphanol Tartrate |
| Biohaven Pharmaceuticals, INC. | $169.97 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $116.74 | 2020-2024 | Rexulti |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yun Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.